MEDREH · EP 01 · CARDIAC
Before You Listen
Episode Setup
- Topic in one line: the four-phase American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) framework, the AHA/AACVPR risk stratification tiers, exercise prescription using the Karvonen heart rate reserve formula and rating of perceived exertion (RPE), post-coronary artery bypass grafting (CABG) sternal precautions, the HF-ACTION trial mandate that exercise is safe and beneficial in heart failure with reduced ejection fraction, and the unique denervated physiology of the transplanted heart that demands RPE-based prescription with extended warm-up and cool-down.
- Prerequisites: basic cardiac anatomy and physiology, the ejection fraction concept, the New York Heart Association (NYHA) functional classification, normal autonomic control of heart rate, and the metabolic equivalent of task (MET) framework as a measure of activity intensity.
- Runtime: 1 hour 2 minutes.
Vignette. A 62-year-old man is referred to outpatient cardiac rehabilitation 3 weeks after an inferior wall ST-elevation myocardial infarction managed with primary percutaneous coronary intervention to the right coronary artery. Echocardiogram shows a left ventricular ejection fraction of 35 percent. A symptom-limited exercise treadmill test stops at 4 metabolic equivalents (METs) for fatigue with 1 mm of ST depression. Resting heart rate on his current metoprolol succinate 50 mg daily is 58 beats per minute. He asks what target heart rate range he should aim for during sessions, whether he is safe to exercise, and when he can return to his job loading freight.
What is his AHA/AACVPR risk stratum, what target heart rate range applies at 50 percent of his heart rate reserve using the Karvonen formula, what continuous monitoring is required, and what one finding in the vignette would have made exercise an absolute contraindication?
(Answer at the end of this chapter)
Section 1: The Four AACVPR Phases of Cardiac Rehabilitation
Bottom line: cardiac rehabilitation is organized into four sequential phases — Phase I (inpatient, beginning 24-48 hours after the cardiac event at 1-2 metabolic equivalents (METs) with the delta heart rate (HR) +20, delta systolic blood pressure (SBP) +20 inpatient progression rule), Phase II (outpatient supervised with continuous electrocardiographic (ECG) monitoring, 12-36 sessions over 6-12 weeks, the most heavily tested phase and the one with the strongest mortality evidence), Phase III (late outpatient gym-based with reduced or intermittent monitoring, 3-6 months), and Phase IV (lifetime self-directed maintenance with no clinical monitoring) — and meta-analyses show this continuum cuts all-cause mortality 20-25 percent and cardiovascular mortality 25-30 percent, yet only 20-30 percent of eligible patients ever enroll, with the gap widening for women, racial and ethnic minorities, the elderly, and rural populations.
The cardiac rehabilitation continuum begins in the hospital bed and ends with the patient exercising independently for the rest of their life. Each of the four phases has a defined setting, intensity, monitoring intensity, duration, and primary goal, and the board expects rapid recognition of which phase a vignette is describing.
Phase I is the inpatient phase. It begins 24 to 48 hours after the cardiac event (myocardial infarction (MI), CABG, valve surgery, percutaneous coronary intervention (PCI), or heart failure exacerbation) and continues until hospital discharge. Activity is limited to 1 to 2 METs, which corresponds to basic self-care: eating, bedside bathing, and short ambulation. Continuous telemetry monitors heart rhythm. Goals are early mobilization to prevent venous thromboembolism and deconditioning, patient and family education, and discharge planning that confirms the patient can ambulate 200 feet on level ground and climb a short flight of stairs if home access requires it. Phase I includes a specific board-tested progression rule: during early monitored ambulation after MI, heart rate may rise no more than 20 beats per minute and systolic blood pressure no more than 20 mmHg from resting baseline during a single activity session. Exceeding either threshold, or developing angina, dyspnea, ST changes, new arrhythmias, or a fall in systolic blood pressure greater than 10 mmHg, mandates stopping. This delta HR +20, delta SBP +20 rule is the safety margin for inpatient progression.
Phase II is outpatient supervised cardiac rehabilitation, the most heavily tested phase. It begins 1 to 3 weeks after discharge. The standard course is 12 to 36 sessions over 6 to 12 weeks, 2 to 3 sessions per week. Each one-hour session includes warm-up, aerobic exercise, resistance training, cool-down, and risk-factor education. The defining feature is continuous ECG monitoring during exercise. Trained staff monitor rhythm, heart rate, and blood pressure. Exercise prescription is individualized using the exercise test result, AHA/AACVPR risk stratification, and the Karvonen formula. Phase II carries the strongest mortality evidence: 20-25 percent reduction in all-cause mortality and 25-30 percent reduction in cardiac mortality, plus reduced readmissions and improved quality of life.
Phase III is the late outpatient or maintenance-transition phase. ECG monitoring is intermittent or absent. Patients exercise in a gym-based setting with less clinical oversight. Goals shift toward independence in exercise habits, advancement of the prescription, and continued risk-factor modification. Phase III programs typically last 3 to 6 months.
Phase IV is lifetime maintenance: self-directed independent exercise. There is no clinical monitoring. The patient has internalized the prescription, recognizes warning symptoms, and partners with primary care and cardiology on long-term risk-factor management.
A vignette of a patient 6 weeks after MI exercising on a treadmill with continuous ECG monitoring in a supervised outpatient facility describes Phase II. A patient on telemetry walking the hospital hallway 2 days after CABG is Phase I. Self-directed walking 8 months after the event with no monitoring is Phase IV. The setting and monitoring intensity together identify the phase.
High Yield — AACVPR phases
- Phase I: inpatient, 24-48 h post-event, 1-2 METs, continuous telemetry, delta HR +20, delta SBP +20 progression rule.
- Phase II: outpatient supervised, 1-3 wk post-discharge, 12-36 sessions / 6-12 wk, 2-3x/week, continuous ECG monitoring, the heart of the program.
- Phase III: late outpatient, intermittent or no ECG, 3-6 months, gym-based, building independence.
- Phase IV: lifetime self-directed, no monitoring, internalized prescription.
- Mortality benefit: all-cause -20 to 25 percent, cardiovascular -25 to 30 percent (meta-analyses).
- Enrollment gap: only 20-30 percent of eligible patients enroll; gap widens for women, minorities, elderly, rural.
Mnemonic — “I-Bed, II-Belt, III-Gym, IV-Forever”
Inpatient = Bedside mobilization, telemetry on. II = Belt of the ECG monitor, supervised on the treadmill. III = Gym with intermittent oversight. IV = Forever, fully on your own. The setting and monitoring intensity diagnose the phase.
If you let their heart rate or blood pressure spike, you increase the myocardial oxygen demand beyond what their newly stented or bypassed coronary arteries can supply. You risk extending the infarct or triggering a fatal arrhythmia. That Delta 20 rule defines your absolute safety margin.
— MEDREH-01 podcast, ~09:08